Originally published December 7 2005
Research suggests melatonin could soon be used in cancer therapy
by Mike Adams, the Health Ranger, NaturalNews Editor
A new study published in the Journal of Pineal Research claims that melatonin could play a major role in future cancer therapies.
Melatonin is a hormone naturally found in humans.
Its association with cancer has been shown in many studies assessing links between shift work and cancer rates, and shown a consistent relationship.
The association between melatonin levels and cancer progression has suggested to some that melatonin may be a modifier of cancer progression.
In this latest study, researchers examined all clinical trials assessing the role of melatonin as a therapy for solid tumor cancers.
The authors reviewed 10 randomized clinical trials that included a total of 643 cancer patients with a variety of different solid tumor cancers.
The study also showed that melatonin was predominantly safe and had a beneficial effect on sleep patterns of patients.
All of the clinical trials involved in their study were from Europe from a related network of clinical researchers in Italy and Poland.
The researchers, from McMaster University and the University of Toronto in Canada, say that their analysis also shows that clinical trials in North America should have been initiated back in 1996/7 as the results from Europe were consistent at that time.
The Canadian researchers urge caution in interpreting the immediate clinical usefulness of large doses of melatonin and recommend patients discuss this with their physicians before beginning any treatments.
Dr. Dugald Seely, a cancer researcher at Sick Children's Hospital in Toronto and an author on the study, states, "This analysis shows a strong association.
The small number of people needed to treat, low adverse events reported and low costs related to this intervention should be of substantial interest to patients, physicians and policy makers.
Completion of independently conducted studies is required to confirm the efficacy and safety of melatonin in cancer treatment."
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml